You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR BUPROPION HYDROBROMIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for bupropion hydrobromide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02129751 ↗ Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder Not yet recruiting Bausch Health Americas, Inc. Phase 4 2021-11-01 Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety
NCT02129751 ↗ Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder Not yet recruiting Valeant Pharmaceuticals International, Inc. Phase 4 2021-11-01 Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety
NCT02860962 ↗ A Trial of Dextromethorphan for Treatment of Major Depressive Disorder Completed Medical University of South Carolina Phase 1 2016-08-01 A proof-of-concept study to determine the antidepressant potential of Dextromethorphan for treating depression associated with Major Depressive Disorder in inpatients.
NCT03299452 ↗ Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor Unknown status Alphacait, LLC Phase 2 2017-01-01 This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor.
NCT03299452 ↗ Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor Unknown status Haining Health-Coming Biotech Co., Ltd. Phase 2 2017-01-01 This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for bupropion hydrobromide

Condition Name

Condition Name for bupropion hydrobromide
Intervention Trials
Major Depressive Disorder 2
Metastatic Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for bupropion hydrobromide
Intervention Trials
Depressive Disorder, Major 2
Depressive Disorder 2
Depression 2
Disease 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for bupropion hydrobromide

Trials by Country

Trials by Country for bupropion hydrobromide
Location Trials
China 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for bupropion hydrobromide
Location Trials
New Jersey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for bupropion hydrobromide

Clinical Trial Phase

Clinical Trial Phase for bupropion hydrobromide
Clinical Trial Phase Trials
Phase 4 1
Phase 2 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for bupropion hydrobromide
Clinical Trial Phase Trials
Unknown status 1
Completed 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for bupropion hydrobromide

Sponsor Name

Sponsor Name for bupropion hydrobromide
Sponsor Trials
Bausch Health Americas, Inc. 1
Valeant Pharmaceuticals International, Inc. 1
Medical University of South Carolina 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for bupropion hydrobromide
Sponsor Trials
Other 3
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.